[Clinico-immunologic substantiation of the use of diucifon in patients with chronic tonsillitis].
D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology*; D002908:Chronic Disease; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D012397:Rosette Formation; D013450:Sulfones / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology*; D014069:Tonsillitis / Q000188:drug therapy* / Q000276:immunology; D014498:Uracil / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004338:Drug Combinations; D013450:Sulfones; C023367:diucifon; D014498:Uracil
Kliniko-immunologicheskoe obosnovanie primeneniia diutsifona u bol'nykh khronicheskim tonzillitom.